The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...

If you’ve ever watched Shark Tank, you probably know Barbara Corcoran. On the show, she invests in businesses, but away from ...

While investigations into the drug are stopping in Alzheimer’s disease, the therapy is now being evaluated in TSC-related ...

Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era ...

With a strong network of associates, residents, families and business partners, Brookdale participated in Walk to End Alzheimer's events across the country in 2024, making a sizable impact through ...

The Ironman Triathlon is a grueling 140 miles, which includes a 2.4-mile swim, a 112-mile bike ride and a 26.2-mile marathon ...

A man diagnosed with Alzheimer's at 41 shared that his 'brain has had enough' by the end of each day, after revealing ...

Hospice care typically involves a multidisciplinary team of healthcare professionals, each specializing in different aspects ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Melisa Miller Mote, co-chair of the River Region Walk To End Alzheimer's, joined the Greenville Lions club meeting0, ...

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...